drugset / Trial / NCT02979223

Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation

NCT02979223

Phase 2 Completed 142 enrolled National Cancer Center, Korea
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The aim of this study is to compare the efficacy depending on the order of the sequential combination method using sodium picosulfate and magnesium citrate (PMC) and PEG with ascorbic acid for bowel preparation. The investigators designed this study as a phase II prospective randomized parallel arm clinical trial. 71 participant will be enrolled in each group (142 in total). The primary outcome is the efficacy of bowel preparation. secondary outcomes are tolerability, side effect of the drugs, polyp detection rate and adenoma detection rate.

Timeline

Start
2016-11
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Citrate Unknown Oral
Subject Sodium Picosulfate Unknown Oral
Subject Vitamin C Other / unclassified Oral
Subject polyethylene glycol Other / unclassified Oral

Indications

No indication recorded.